Vanguard Group
BDSI

Vanguard Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Vanguard Group’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,742,364
Closed -$14.7M – 4698
2021
Q4 		$14.7M Buy
4,742,364
+35,313
+0.8% +$119K ﹤0.01% 3007
2021
Q3 		$17M Sell
4,707,051
-298,964
-6% -$1.13M ﹤0.01% 2950
2021
Q2 		$17.9M Sell
5,006,015
-266,665
-5% -$941K ﹤0.01% 2908
2021
Q1 		$20.6M Buy
5,272,680
+464,572
+10% +$1.92M ﹤0.01% 2768
2020
Q4 		$20.2M Buy
4,808,108
+201,389
+4% +$776K ﹤0.01% 2627
2020
Q3 		$17.2M Sell
4,606,719
-81,753
-2% -$348K ﹤0.01% 2537
2020
Q2 		$20.4M Buy
4,688,472
+826,762
+21% +$3.72M ﹤0.01% 2416
2020
Q1 		$14.6M Buy
3,861,710
+44,339
+1% +$218K ﹤0.01% 2434
2019
Q4 		$24.1M Buy
3,817,371
+68,941
+2% +$405K ﹤0.01% 2436
2019
Q3 		$15.8M Buy
3,748,430
+353,002
+10% +$1.51M ﹤0.01% 2590
2019
Q2 		$15.8M Buy
3,395,428
+793,179
+30% +$3.69M ﹤0.01% 2633
2019
Q1 		$13.8M Buy
2,602,249
+58,750
+2% +$268K ﹤0.01% 2668
2018
Q4 		$9.41M Buy
2,543,499
+163,043
+7% +$573K ﹤0.01% 2799
2018
Q3 		$6.67M Buy
2,380,456
+7,600
+0.3% +$21.3K ﹤0.01% 3127
2018
Q2 		$7M Buy
2,372,856
+15,869
+0.7% +$37.6K ﹤0.01% 3072
2018
Q1 		$5.3M Sell
2,356,987
-10,173
-0.4% -$23.8K ﹤0.01% 3128
2017
Q4 		$6.98M Buy
2,367,160
+50,283
+2% +$139K ﹤0.01% 2995
2017
Q3 		$6.83M Buy
2,316,877
+356,747
+18% +$1.09M ﹤0.01% 2990
2017
Q2 		$5.49M Sell
1,960,130
-311,389
-14% -$657K ﹤0.01% 3051
2017
Q1 		$4.32M Buy
2,271,519
+44,036
+2% +$84.9K ﹤0.01% 3110
2016
Q4 		$3.9M Buy
2,227,483
+195,884
+10% +$400K ﹤0.01% 3145
2016
Q3 		$5.49M Buy
2,031,599
+161,413
+9% +$410K ﹤0.01% 2955
2016
Q2 		$4.41M Buy
1,870,186
+29,877
+2% +$82.4K ﹤0.01% 3049
2016
Q1 		$5.95M Sell
1,840,309
-14,867
-0.8% -$54.9K ﹤0.01% 2875
2015
Q4 		$8.89M Buy
1,855,176
+101,770
+6% +$577K ﹤0.01% 2701
2015
Q3 		$9.75M Buy
1,753,406
+80,808
+5% +$596K ﹤0.01% 2621
2015
Q2 		$13.3M Buy
1,672,598
+73,674
+5% +$633K ﹤0.01% 2531
2015
Q1 		$16.8M Buy
1,598,924
+92,449
+6% +$1.26M ﹤0.01% 2401
2014
Q4 		$18.1M Buy
1,506,475
+200,517
+15% +$3.05M ﹤0.01% 2272
2014
Q3 		$22.3M Buy
1,305,958
+127,038
+11% +$1.84M ﹤0.01% 2162
2014
Q2 		$14.2M Buy
1,178,920
+107,971
+10% +$1.02M ﹤0.01% 2355
2014
Q1 		$9.04M Buy
1,070,949
+248,527
+30% +$2.01M ﹤0.01% 2540
2013
Q4 		$4.84M Buy
822,422
+27,343
+3% +$141K ﹤0.01% 2814
2013
Q3 		$4.32M Buy
795,079
+54,678
+7% +$263K ﹤0.01% 2816
2013
Q2 		$3.01M Buy
+740,401
New +$3.47M ﹤0.01% 2917

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Vanguard Group's BDSI Position: Q1 2022 in Review

Vanguard Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 4,742,364 shares — an estimated $14.7M sold.

Vanguard Group first reported a position in BDSI in Q2 2013 and held it in 35 quarters. The position peaked at $24.1M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Vanguard Group reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Vanguard Group sold 4,742,364 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $14.7M.
  • Vanguard Group first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 35 quarters.
  • Vanguard Group's BioDelivery Sciences International, Inc. position peaked at $24.1M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Vanguard Group's 13F filing for Q1 2022, filed 13 May 2022.